Skip to content
10-K

Annual Report

PHARMACYCLICS INC

0001628280-15-000826

← back to feed
Filed
Feb 18, 2015 12:00 AM ET
Period of report
—
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Feb 12, 2015 76.02M sh
Shares Diluted FY 2014 · Dec 31, 2014 78.47M sh
Shares Diluted FY 2014 · Dec 31, 2014 78.15M sh
Shares Diluted FY 2014 · Sep 30, 2014 78.03M sh
Shares Diluted FY 2014 · Jun 30, 2014 75.14M sh
Shares Diluted FY 2014 · Mar 31, 2014 78.06M sh
Shares Diluted FY 2014 · Dec 31, 2013 77.92M sh
Shares Diluted FY 2014 · Dec 31, 2013 77.08M sh
Shares Diluted FY 2014 · Sep 30, 2013 77.66M sh
Shares Diluted FY 2014 · Jun 30, 2013 77.19M sh
Shares Diluted FY 2014 · Mar 31, 2013 70.93M sh
Shares Diluted FY 2014 · Dec 31, 2012 74.41M sh
Shares Diluted FY 2014 · Jun 30, 2012 72.62M sh
Shares Diluted FY 2014 · Dec 31, 2011 71.31M sh
Capex FY 2014 · Dec 31, 2014 $13.92M
Capex FY 2014 · Dec 31, 2013 $18.32M
Capex FY 2014 · Dec 31, 2012 $2.42M
Capex FY 2014 · Jun 30, 2012 $2.98M
Operating Cash Flow FY 2014 · Dec 31, 2014 $183.77M
Operating Cash Flow FY 2014 · Dec 31, 2013 $88.77M
Operating Cash Flow FY 2014 · Dec 31, 2012 $110.69M
Operating Cash Flow FY 2014 · Jun 30, 2012 $86.09M
Operating Cash Flow FY 2014 · Dec 31, 2011 $123.9M
Cash And Equivalents FY 2014 · Dec 31, 2014 $845.04M
Cash And Equivalents FY 2014 · Dec 31, 2013 $623.96M
Cash And Equivalents FY 2014 · Dec 31, 2012 $307.43M
Cash And Equivalents FY 2014 · Jun 30, 2012 $197.9M
Cash And Equivalents FY 2014 · Jun 30, 2011 $87.76M
Stockholders Equity FY 2014 · Dec 31, 2014 $829.17M
Stockholders Equity FY 2014 · Dec 31, 2013 $627.62M
Stockholders Equity FY 2014 · Dec 31, 2012 $262.53M
Stockholders Equity FY 2014 · Jun 30, 2012 $132.12M
Stockholders Equity FY 2014 · Jun 30, 2011 $101.67M
Current Liabilities FY 2014 · Dec 31, 2014 $194.24M
Current Liabilities FY 2014 · Dec 31, 2013 $87.63M
Total Liabilities FY 2014 · Dec 31, 2014 $230.94M
Total Liabilities FY 2014 · Dec 31, 2013 $141.13M
Current Assets FY 2014 · Dec 31, 2014 $1.02B
Current Assets FY 2014 · Dec 31, 2013 $740.8M
Total Assets FY 2014 · Dec 31, 2014 $1.06B
Total Assets FY 2014 · Dec 31, 2013 $768.75M
Eps Diluted FY 2014 · Dec 31, 2014 $0.81
Eps Diluted FY 2014 · Dec 31, 2014 $1.10
Eps Diluted FY 2014 · Sep 30, 2014 $0.53
Eps Diluted FY 2014 · Jun 30, 2014 −$0.49
Eps Diluted FY 2014 · Mar 31, 2014 $0.23
Eps Diluted FY 2014 · Dec 31, 2013 $0.82
Eps Diluted FY 2014 · Dec 31, 2013 $0.87
Eps Diluted FY 2014 · Sep 30, 2013 $0.55
Eps Diluted FY 2014 · Jun 30, 2013 $0.16
Eps Diluted FY 2014 · Mar 31, 2013 −$0.73
Eps Diluted FY 2014 · Dec 31, 2012 $1.58
Eps Diluted FY 2014 · Jun 30, 2012 $0.17
Eps Diluted FY 2014 · Dec 31, 2011 $0.58
Eps Basic FY 2014 · Dec 31, 2014 $0.84
Eps Basic FY 2014 · Dec 31, 2014 $1.14
Eps Basic FY 2014 · Sep 30, 2014 $0.55
Eps Basic FY 2014 · Jun 30, 2014 −$0.49
Eps Basic FY 2014 · Mar 31, 2014 $0.24
Eps Basic FY 2014 · Dec 31, 2013 $0.87
Eps Basic FY 2014 · Dec 31, 2013 $0.92
Eps Basic FY 2014 · Sep 30, 2013 $0.58
Eps Basic FY 2014 · Jun 30, 2013 $0.17
Eps Basic FY 2014 · Mar 31, 2013 −$0.73
Eps Basic FY 2014 · Dec 31, 2012 $1.69
Eps Basic FY 2014 · Jun 30, 2012 $0.17
Eps Basic FY 2014 · Dec 31, 2011 $0.61
Sga Expense FY 2014 · Dec 31, 2014 $167.96M
Sga Expense restated FY 2014 · Dec 31, 2013 $73.61M
Sga Expense restated FY 2014 · Dec 31, 2012 $11.27M
Sga Expense FY 2014 · Jun 30, 2012 $15.58M
Sga Expense FY 2014 · Dec 31, 2011 $7.29M
Rd Expense FY 2014 · Dec 31, 2014 $172.46M
Rd Expense FY 2014 · Dec 31, 2013 $85.13M
Rd Expense FY 2014 · Dec 31, 2012 $29.33M
Rd Expense FY 2014 · Jun 30, 2012 $54.54M
Rd Expense FY 2014 · Dec 31, 2011 $23.32M
Net Income FY 2014 · Dec 31, 2014 $63.48M
Net Income FY 2014 · Dec 31, 2014 $86.12M
Net Income FY 2014 · Sep 30, 2014 $41.42M
Net Income FY 2014 · Jun 30, 2014 −$37.06M
Net Income FY 2014 · Mar 31, 2014 $18.28M
Net Income FY 2014 · Dec 31, 2013 $64.24M
Net Income FY 2014 · Dec 31, 2013 $67.01M
Net Income FY 2014 · Sep 30, 2013 $42.33M
Net Income FY 2014 · Jun 30, 2013 $12.35M
Net Income FY 2014 · Mar 31, 2013 −$51.91M
Net Income FY 2014 · Dec 31, 2012 $117.53M
Net Income FY 2014 · Jun 30, 2012 $11.99M
Net Income FY 2014 · Dec 31, 2011 $41.72M
Operating Income FY 2014 · Dec 31, 2014 $92.99M
Operating Income FY 2014 · Dec 31, 2014 $122.38M
Operating Income FY 2014 · Sep 30, 2014 $48.37M
Operating Income FY 2014 · Jun 30, 2014 −$37.2M
Operating Income FY 2014 · Mar 31, 2014 $18.23M
Operating Income FY 2014 · Dec 31, 2013 $85.43M
Operating Income FY 2014 · Dec 31, 2013 $97.92M
Operating Income FY 2014 · Sep 30, 2013 $53.43M
Operating Income FY 2014 · Jun 30, 2013 $12.03M
Operating Income FY 2014 · Mar 31, 2013 −$52.96M
Operating Income FY 2014 · Dec 31, 2012 $120.05M
Operating Income FY 2014 · Jun 30, 2012 $11.88M
Operating Income FY 2014 · Dec 31, 2011 $47.32M
Cost Of Revenue FY 2014 · Dec 31, 2014 $40.41M
Cost Of Revenue FY 2014 · Dec 31, 2013 $3.5M
Cost Of Revenue FY 2014 · Dec 31, 2012 $0
Cost Of Revenue FY 2014 · Jun 30, 2012 $0
Revenue FY 2014 · Dec 31, 2014 $290.19M
Revenue FY 2014 · Dec 31, 2014 $729.73M
Revenue FY 2014 · Sep 30, 2014 $207.14M
Revenue FY 2014 · Jun 30, 2014 $113.02M
Revenue FY 2014 · Mar 31, 2014 $119.38M
Revenue FY 2014 · Dec 31, 2013 $123.55M
Revenue FY 2014 · Dec 31, 2013 $260.17M
Revenue FY 2014 · Sep 30, 2013 $79.09M
Revenue FY 2014 · Jun 30, 2013 $54.68M
Revenue FY 2014 · Mar 31, 2013 $2.85M
Revenue FY 2014 · Dec 31, 2012 $160.66M
Revenue FY 2014 · Jun 30, 2012 $81.99M
Revenue FY 2014 · Dec 31, 2011 $77.94M
Stock Issued FY 2014 · Mar 31, 2013 2.2M sh